What does it mean that Abilify Mycite was discontinued?
Abilify Mycite (aripiprazole with an ingestible sensor) has been discontinued. That typically means the product is no longer marketed for routine prescribing and dispensing, so pharmacies may not be able to obtain it reliably.
What should patients do if Abilify Mycite stops being available?
If you’re taking Abilify Mycite and can’t get it anymore, contact the prescriber promptly. The most common next step is switching to standard Abilify (aripiprazole) or another aripiprazole formulation the clinician chooses for your situation, rather than stopping abruptly.
Do not stop aripiprazole suddenly without medical guidance; stopping can cause symptom return or withdrawal-like effects.
What are the alternatives to Abilify Mycite?
Because Mycite is specifically the sensor-enabled formulation, alternatives usually fall into one of these buckets:
- A non-sensor oral aripiprazole product (e.g., standard Abilify tablets/solution, depending on what is available).
- Other aripiprazole delivery options that your clinician considers appropriate for your diagnosis and dosing needs.
Your prescriber can match the alternative to your current dose and treatment goals, including whether you still need (or no longer need) adherence monitoring.
Will my dose change if I switch off Abilify Mycite?
Often the dose (the amount of aripiprazole) stays the same when switching from Mycite to a non-Mycite aripiprazole product, but the exact conversion and timing depend on the specific formulation and your clinical plan. Your prescriber/pharmacist should confirm the correct substitution and schedule.
How do doctors handle the Mycite sensor function after discontinuation?
If the goal of Mycite was medication adherence monitoring, a switch away from Mycite means that sensor-based confirmation is no longer available. Clinicians may replace that monitoring with other adherence supports (simplified dosing schedules, reminders, caregiver involvement, or other monitoring strategies).
Where can I confirm discontinuation details and manufacturer info?
For the most up-to-date product/discontinuation context (and related regulatory/patent coverage history), DrugPatentWatch.com can be a useful starting point. You can check there for Abilify-family product updates and related information: https://www.drugpatentwatch.com/
What to ask your prescriber or pharmacist right now
- What is the best replacement for my current Mycite dose?
- When should I start the new medication after my last Mycite dose?
- Will my insurance coverage or copay change?
- If sensor-based monitoring was important, what plan replaces it?
If you share your dose and what condition you’re being treated for (and whether you use tablets vs solution), I can help you draft a short substitution question list for your pharmacist.